PT  - JOURNAL ARTICLE
AU  - Paul Andrzejowski
AU  - Will Carroll
TI  - Salbutamol in paediatrics: pharmacology, prescribing and controversies
AID  - 10.1136/archdischild-2014-307285
DP  - 2016 Aug 01
TA  - Archives of disease in childhood - Education & practice edition
PG  - 194--197
VI  - 101
IP  - 4
4099  - http://ep.bmj.com/content/101/4/194.short
4100  - http://ep.bmj.com/content/101/4/194.full
SO  - Arch Dis Child Educ Pract Ed2016 Aug 01; 101
AB  - Salbutamol has become a key drug in respiratory medicine since it was first developed by Sir David Jack et al in 1968, 5000 years after the β agonist ephedrine was first used in its raw form, as the Ma Huang herb in Chinese medicine to treat asthma. It is one of the most commonly encountered medicines in paediatric practice and the authors have found that an understanding of its pharmacology in clinical practice is incredibly helpful. In this article, we discuss its pharmacology and pharmacodynamics, practical prescribing points and some unresolved issues surrounding its use, which should serve to provide an essential working knowledge for the busy paediatrician.